Weight loss drugs are predicted to reduce GDP spending on obesity-related maladies by one-third, making 5% of GDP, or $14 trillion annually (based on a $28 trillion economy), available each year.
"if these weight loss drugs would only reduce that by a third that would be basically five 5% of GDP available every year we have a $28 trillion economy that's $14 trillion a year"
